AP
AtonRa Partners Portfolio holdings
AUM
$50.2M
This Quarter Return
+7.96%
1 Year Return
+47.76%
3 Year Return
+48.37%
5 Year Return
–
10 Year Return
–
AUM
$224M
AUM Growth
+$224M
(+10%)
Cap. Flow
+$22.6M
Cap. Flow
% of AUM
10.08%
Top 10 Holdings %
Top 10 Hldgs %
22.39%
Holding
140
New
33
Increased
51
Reduced
24
Closed
32
Top Buys
| 1 |
Riot Platforms
RIOT
|
$3.87M |
| 2 |
CrowdStrike
CRWD
|
$2.87M |
| 3 |
Schrodinger
SDGR
|
$2.83M |
| 4 |
SI
Silvergate Capital Corporation
SI
|
$2.78M |
| 5 |
Zscaler
ZS
|
$2.52M |
Top Sells
| 1 |
SPLK
Splunk Inc
SPLK
|
$3.75M |
| 2 |
Tencent Music
TME
|
$3.44M |
| 3 |
Amazon
AMZN
|
$3.18M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
$2.35M |
| 5 |
Broadridge
BR
|
$2.23M |
Sector Composition
| 1 | Technology | 41.92% |
| 2 | Healthcare | 36.47% |
| 3 | Financials | 8.14% |
| 4 | Industrials | 5.95% |
| 5 | Consumer Discretionary | 3.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Biogen
BIIB
$19.4B
| $774K | 0.35% |
+2,767
| New | +$774K |
|
102
3D Systems Corporation
DDD
$295M
| $700K | 0.31% |
+25,514
| New | +$700K |
|
103
Guidewire Software
GWRE
$18.3B
| $564K | 0.25% |
5,551
-16,498
| -75% | -$1.68M |
|
104
BioMarin Pharmaceuticals
BMRN
$11.2B
| $561K | 0.25% |
7,429
+1,507
| +25% | +$114K |
|
|
CBAY
105
DELISTED
Cymabay Therapeutics
CBAY
| $506K | 0.23% |
111,525
+23,544
| +27% | +$107K |
|
106
American Well
AMWL
$111M
| $501K | 0.22% |
+28,860
| New | +$501K |
|
107
Seres Therapeutics
MCRB
$166M
| $448K | 0.2% |
21,762
+4,869
| +29% | +$100K |
|
108
HealthEquity
HQY
$7.72B
| – | – |
-9,802
| Closed | -$683K |
|
109
iRhythm Technologies
IRTC
$5.46B
| – | – |
-3,513
| Closed | -$833K |
|
110
Apple
AAPL
$3.45T
| – | – |
-5,266
| Closed | -$699K |
|
111
Akamai
AKAM
$11.3B
| – | – |
-9,246
| Closed | -$971K |
|
|
112
Amazon
AMZN
$2.44T
| – | – |
-976
| Closed | -$3.18M |
|
113
Bio-Rad Laboratories Class A
BIO
$8.06B
| – | – |
-2,289
| Closed | -$1.33M |
|
|
114
Broadridge
BR
$29.9B
| – | – |
-14,582
| Closed | -$2.23M |
|
115
Datadog
DDOG
$47.7B
| – | – |
-5,910
| Closed | -$582K |
|
116
Danaher
DHR
$147B
| – | – |
-3,207
| Closed | -$712K |
|
117
Esperion Therapeutics
ESPR
$448M
| – | – |
-16,139
| Closed | -$420K |
|
118
Exelixis
EXEL
$10.1B
| – | – |
-103,080
| Closed | -$2.07M |
|
119
Alphabet (Google) Class A
GOOGL
$2.57T
| – | – |
-356
| Closed | -$624K |
|
120
Jack Henry & Associates
JKHY
$11.9B
| – | – |
-5,632
| Closed | -$912K |
|
121
Leidos
LDOS
$23.2B
| – | – |
-11,394
| Closed | -$1.2M |
|
|
LX
122
LexinFintech Holdings
LX
$1.06B
| – | – |
-57,544
| Closed | -$386K |
|
123
Microsoft
MSFT
$3.77T
| – | – |
-3,257
| Closed | -$724K |
|
124
Omnicell
OMCL
$1.5B
| – | – |
-11,655
| Closed | -$1.4M |
|
125
Quince Therapeutics
QNCX
$85.9M
| – | – |
-19,003
| Closed | -$528K |
|